| Oral Liposomal Iron Versus Injectable Iron Sucrose for Anemia Treatment in Non-Dialysis Chronic Kidney Disease Patients (NCT06556134) | Centre Hospitalier Hassan II - Fès | 2021-07-01 |
| A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD) (NCT04655027) | AstraZeneca | 2021-02-22 |
| Roxadustat for Anemia in Patients With CKD (NCT04502537) | Shenzhen Second People's Hospital | 2021-02-01 |
| Erythropoiesis Stimulating Agents for Anemia Management in Egyptian Hemodialysis Patients (NCT05699109) | Helwan University | 2021-01-01 |
| PBF-1681 (Ferric Citrate) for the Treatment of IDA in Patients With NDD-CKD (NCT04543812) | Panion & BF Biotech Inc. | 2020-10-14 |
| Investigation of the Effects of Medium Cut-off Dialyzers Versus High-Flux Dialyzers on Clinical and Laboratory Parameters of Prevalent Hemodialysis Patients (NCT05698420) | Sanliurfa Mehmet Akif Inan Education and Research Hospital | 2020-03-01 |
| Project Aura: Co-design of a Home-based Monitoring Service (NCT04112615) | Entia Ltd | 2020-02-17 |
| Iron Dosing Pilot Study Using Model Predictive Control (NCT03633656) | University of Louisville | 2019-02-01 |
| A Study to Evaluate Efficacy and Safety of JTZ-951 Compared to Darbepoetin Alfa in Korean Renal Anemia Patients Receiving Hemodialysis. (NCT04027517) | JW Pharmaceutical | 2019-01-15 |
| Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant Patient (NCT03193073) | Omnia Mohammed Hashem | 2018-09-01 |
| Study of HEMAX PFS Versus EPREX/ ERYPO® in Predialysis Chronic Kidney Disease (NCT04036253) | Bio Sidus SA | 2018-02-28 |
| Comparison of Darbepoetin Alpha and Recombinant Human Erythropoietin for Treatment of Anemia in Children With Chronic Kidney Disease (NCT04959578) | Rufaida Mazahir | 2018-02-01 |
| Does Oral Pentoxifylline Administration Improve Hemoglobin in Hemodialysis Patients? (NCT03731741) | Tanta University | 2017-11-01 |
| Phase 2a Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients (NCT03325621) | Pieris Pharmaceuticals GmbH | 2017-09-30 |
| Effect of Erythropoiesis-Stimulating Agent Therapy in Patients Receiving Palliative Care of Chronic Kidney Disease (NCT03427801) | Chinese University of Hong Kong | 2017-03-01 |
| Phase Ib Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients (NCT02754167) | Pieris Pharmaceuticals GmbH | 2016-06-06 |
| Mass Balance Study of JTZ-951 in Subjects With End-stage Renal Disease on Hemodialysis (NCT02805244) | Akros Pharma Inc. | 2016-06-01 |
| Periodic Versus Continuous IV Iron Supplementation in HD Patients (NCT02787824) | Papageorgiou General Hospital | 2016-05-01 |
| To Evaluate the Efficacy, Safety, and Immunogenicity of Subcutaneous Eporon Versus Epoetin Alfa (Eprex) (NCT03521713) | Dong-A ST Co., Ltd. | 2016-03-01 |
| Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease (NCT02581124) | Akros Pharma Inc. | 2015-10-01 |
| CKD-11101 Phase 3 IV Study in Patients Who Had Renal Anemia Receiving Hemodialysis (NCT03428594) | Chong Kun Dang Pharmaceutical | 2015-06-01 |
| CKD-11101 Phase 3 SC Study (NCT03431623) | Chong Kun Dang Pharmaceutical | 2015-05-01 |
| KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD (NCT02268994) | Keryx Biopharmaceuticals | 2014-10-01 |
| Comparison Study of Two Iron Compounds for Treatment of Anemia in Hemodialysis Patients (NCT02198495) | Medical University of Vienna | 2014-09-01 |
| A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia (NCT02128074) | Keryx Biopharmaceuticals | 2014-04-01 |
| Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease (NCT01971164) | Akros Pharma Inc. | 2013-05-01 |
| Vitamin D as a Modifier of Serum Hepcidin in Children With Chronic Kidney Disease (NCT01532349) | Johns Hopkins University | 2012-05-01 |